ATR and ovarian carcinoma: In clear contrast, dual ATM/ATR inhibition strongly potentiates the activity of both ETs against human cervical and ovarian carcinoma cells by efficiently blocking the formation of γ-H2AX, MDC1, BRCA1 and Rad51 foci following ET-exposure thereby resulting in extensive chromosome damage.